Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1978 1
1981 1
1984 1
1987 2
1988 1
1989 4
1990 8
1991 2
1992 5
1993 3
1994 5
1995 4
1996 7
1997 4
1998 5
1999 4
2000 5
2001 8
2002 11
2003 7
2004 12
2005 14
2006 12
2007 7
2008 4
2009 10
2010 7
2011 10
2012 13
2013 10
2014 7
2015 14
2016 16
2017 18
2018 15
2019 11
2020 5
2021 7
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

269 results
Results by year
Filters applied: . Clear all
Page 1
GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance.
Luan HH, Wang A, Hilliard BK, Carvalho F, Rosen CE, Ahasic AM, Herzog EL, Kang I, Pisani MA, Yu S, Zhang C, Ring AM, Young LH, Medzhitov R. Luan HH, et al. Among authors: young lh. Cell. 2019 Aug 22;178(5):1231-1244.e11. doi: 10.1016/j.cell.2019.07.033. Epub 2019 Aug 8. Cell. 2019. PMID: 31402172 Free PMC article.
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.
Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, Brass LM, Schwartz GG, Adams HP Jr, Berger L, Carolei A, Clark W, Coull B, Ford GA, Kleindorfer D, O'Leary JR, Parsons MW, Ringleb P, Sen S, Spence JD, Tanne D, Wang D, Winder TR; IRIS Trial Investigators. Kernan WN, et al. Among authors: young lh. N Engl J Med. 2016 Apr 7;374(14):1321-31. doi: 10.1056/NEJMoa1506930. Epub 2016 Feb 17. N Engl J Med. 2016. PMID: 26886418 Free PMC article. Clinical Trial.
International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.
Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, White RI, Young LH, Zarrabeitia R; HHT Foundation International - Guidelines Working Group. Faughnan ME, et al. Among authors: young lh. J Med Genet. 2011 Feb;48(2):73-87. doi: 10.1136/jmg.2009.069013. Epub 2009 Jun 23. J Med Genet. 2011. PMID: 19553198 Free article.
Ocular siderosis.
Sandhu HS, Young LH. Sandhu HS, et al. Among authors: young lh. Int Ophthalmol Clin. 2013 Fall;53(4):177-84. doi: 10.1097/IIO.0b013e3182a5b58f. Int Ophthalmol Clin. 2013. PMID: 24088944 Review. No abstract available.
Sympathetic ophthalmia.
Chang GC, Young LH. Chang GC, et al. Among authors: young lh. Semin Ophthalmol. 2011 Jul-Sep;26(4-5):316-20. doi: 10.3109/08820538.2011.588658. Semin Ophthalmol. 2011. PMID: 21958181 Review.
Cytomegalovirus retinitis.
Wiegand TW, Young LH. Wiegand TW, et al. Among authors: young lh. Int Ophthalmol Clin. 2006 Spring;46(2):91-110. doi: 10.1097/00004397-200604620-00010. Int Ophthalmol Clin. 2006. PMID: 16770157 Review. No abstract available.
Sympathetic ophthalmia.
Damico FM, Kiss S, Young LH. Damico FM, et al. Among authors: young lh. Semin Ophthalmol. 2005 Jul-Sep;20(3):191-7. doi: 10.1080/08820530500232100. Semin Ophthalmol. 2005. PMID: 16282154 Review.
Vogt-Koyanagi-Harada disease.
Damico FM, Kiss S, Young LH. Damico FM, et al. Among authors: young lh. Semin Ophthalmol. 2005 Jul-Sep;20(3):183-90. doi: 10.1080/08820530500232126. Semin Ophthalmol. 2005. PMID: 16282153 Review.
NAD Repletion Therapy: A Silver Bullet for HFpEF?
Akar FG, Young LH. Akar FG, et al. Among authors: young lh. Circ Res. 2021 May 28;128(11):1642-1645. doi: 10.1161/CIRCRESAHA.121.319308. Epub 2021 May 27. Circ Res. 2021. PMID: 34043421 Free PMC article. No abstract available.
Management of ocular toxoplasmosis.
Koo L, Young LH. Koo L, et al. Among authors: young lh. Int Ophthalmol Clin. 2006 Spring;46(2):183-93. doi: 10.1097/00004397-200604620-00015. Int Ophthalmol Clin. 2006. PMID: 16770162 Review. No abstract available.
269 results